Yu‐Yi Chu
- Oncology top 5%
- Immunology top 5%
- Molecular Biology
- Cancer Research
- Pulmonary and Respiratory Medicine
- Co-authors
- Chun‐Yen LinChing‐Tai HuangJayashri MahalingamYung‐Chang LinJu-Ming WangLi-Yuan ChangChiao-Wen KangAvijit Dutta
- Topics
- Immune Cell Function and Interaction (8 papers)Cancer Immunotherapy and Biomarkers (5 papers)Immunotherapy and Immune Responses (5 papers)
- Cited by
- ImmunologyOncologyCancer Research
- Partner nations
- TaiwanUnited StatesChina
In The Last Decade
Yu‐Yi Chu
29 papers receiving 1.0k citations
Peers
Comparison fields: 5 of 90
- Oncology 490
- Immunology 466
- Molecular Biology 402
- Cancer Research 146
- Pulmonary and Respiratory Medicine 77
Countries citing papers authored by Yu‐Yi Chu
This map shows the geographic impact of Yu‐Yi Chu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yu‐Yi Chu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yu‐Yi Chu more than expected).
Fields of papers citing papers by Yu‐Yi Chu
This network shows the impact of papers produced by Yu‐Yi Chu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yu‐Yi Chu. The network helps show where Yu‐Yi Chu may publish in the future.
Co-authorship network of co-authors of Yu‐Yi Chu
This figure shows the co-authorship network connecting the top 25 collaborators of Yu‐Yi Chu. A scholar is included among the top collaborators of Yu‐Yi Chu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yu‐Yi Chu. Yu‐Yi Chu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 36 | |
| 2 | 5 | |
| 3 | 23 | |
| 4 | 25 | |
| 5 | Nuclear translocation of the receptor tyrosine kinase c-MET reduces the treatment efficacies of olaparib and gemcitabine in pancreatic ductal adenocarcinoma cells. | 15 |
| 6 | Blocking c-Met and EGFR reverses acquired resistance of PARP inhibitors in triple-negative breast cancer. | 36 |
| 7 | 59 | |
| 8 | 27 | |
| 9 | 51 | |
| 10 | 46 | |
| 11 | 25 | |
| 12 | 136 | |
| 13 | 7 | |
| 14 | 32 | |
| 15 | 28 | |
| 16 | 42 | |
| 17 | 14 | |
| 18 | 189 | |
| 19 | 25 | |
| 20 | 89 |
About Yu‐Yi Chu
Yu‐Yi Chu is a scholar working on Oncology, Immunology and Neurology, having authored 29 papers that have together received 1.1k indexed citations. Recurring topics across this work include Immune Cell Function and Interaction (8 papers), Cancer Immunotherapy and Biomarkers (5 papers) and Immunotherapy and Immune Responses (5 papers). The work is most often cited by research in Immunology (466 citations), Oncology (490 citations) and Cancer Research (146 citations). Yu‐Yi Chu has collaborated with scholars based in Taiwan, United States and China. Frequent co-authors include Chun‐Yen Lin, Ching‐Tai Huang, Jayashri Mahalingam, Yung‐Chang Lin, Ju-Ming Wang, Li-Yuan Chang, Chiao-Wen Kang, Avijit Dutta, Jy‐Ming Chiang and Mien‐Chie Hung. Their work appears in journals such as Journal of Biological Chemistry, The Journal of Immunology and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.